Winvild Tablet SR is a sustained-release formulation combining Pregabalin 75mg, Nortriptyline 10mg, and Methylcobalamin 1500mcg, designed to provide comprehensive management of neuropathic pain and associated conditions. Pregabalin, a gamma-aminobutyric acid (GABA) analogue, modulates calcium channels to reduce neuronal excitability and alleviate neuropathic pain. Nortriptyline, a tricyclic antidepressant, enhances noradrenaline and serotonin levels in the central nervous system, contributing to analgesic effects and improvement of mood disorders often accompanying chronic pain. Methylcobalamin, an active form of vitamin B12, supports nerve regeneration and repair, enhancing peripheral nerve function. The sustained-release mechanism ensures prolonged therapeutic action, improving patient compliance by reducing dosing frequency. Winvild Tablet SR is indicated for diabetic neuropathy, postherpetic neuralgia, peripheral neuropathies, and other chronic neuropathic pain syndromes. It may also benefit patients with depressive symptoms linked to chronic pain. Caution is advised in patients with renal impairment, cardiovascular disorders, or a history of seizures. Common adverse effects include dizziness, somnolence, dry mouth, and gastrointestinal disturbances. Use should be guided by a healthcare professional, with dose adjustments based on clinical response and tolerability. Winvild Tablet SR offers a multimodal approach targeting pain relief, nerve health, and psychological well-being in neuropathic conditions.